Antisense Therapeutics Debt 2024

Antisense Therapeutics Aktienanalyse

What does Antisense Therapeutics do?

Antisense Therapeutics Ltd is an Australian biopharmaceutical company that focuses on developing novel therapies for rare and severe diseases. The company was founded in 1987 and is headquartered in Melbourne. Antisense Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Antisense Therapeutics's Debt Structure

Antisense Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Antisense Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Antisense Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Antisense Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Antisense Therapeutics stock

What is the debt of Antisense Therapeutics this year?

Antisense Therapeutics has a debt level of -0.33 AUD this year.

What was the debt of Antisense Therapeutics compared to the previous year?

The debt of Antisense Therapeutics has increased by -44.84% compared to the previous year dropped.

What are the consequences of high debt for investors in Antisense Therapeutics?

High debt can pose a risk for investors of Antisense Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Antisense Therapeutics?

Low debt means that Antisense Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Antisense Therapeutics affect the company?

An increase in debt of Antisense Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Antisense Therapeutics affect the company?

A reduction in debt of Antisense Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Antisense Therapeutics?

Some factors that can influence the debt of Antisense Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Antisense Therapeutics so important for investors?

The debts of Antisense Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Antisense Therapeutics take to change the debt?

To change the debt, Antisense Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Antisense Therapeutics pay?

Over the past 12 months, Antisense Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Antisense Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Antisense Therapeutics?

The current dividend yield of Antisense Therapeutics is .

When does Antisense Therapeutics pay dividends?

Antisense Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Antisense Therapeutics?

Antisense Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Antisense Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Antisense Therapeutics located?

Antisense Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Antisense Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Antisense Therapeutics from 9/26/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Antisense Therapeutics pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Antisense Therapeutics in the year 2023?

In the year 2023, Antisense Therapeutics distributed 0 AUD as dividends.

In which currency does Antisense Therapeutics pay out the dividend?

The dividends of Antisense Therapeutics are distributed in AUD.